Analyst Reco. Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq Other stock markets 21:30:00 03/05/2024 BST			5-day change	1st Jan Change
3.17 ^USD	+1.93%		+9.31%	+92.12%

04-12	Transcript : Generation Bio Co. - Special Call
03-07	Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	03-07	MT
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating	11-29	MT
Wedbush Lowers Generation Bio's Price Target to $9 From $11, Maintains Outperform Rating	11-10	MT
JMP Securities Downgrades Generation Bio to Market Perform From Market Outperform	23/10/23	MT
TD Cowen Downgrades Generation Bio to Market Perform From Outperform	19/10/23	MT
JPMorgan Chase Adjusts Price Target on Generation Bio to $9 From $8, Maintains Neutral Rating	16/08/23	MT
Wedbush Cuts Generation Bio's Price Target to $11 From $15, Maintains Outperform Rating	23/03/23	MT
Needham Adjusts Price Target on Generation Bio to $14 From $23, Maintains Buy Rating	24/02/23	MT
Wedbush Lowers Generation Bio's PT to $15 From $24, Pushes Out Launch Timings for Each Indication, Adjusts Capital Raise Assumptions; Keeps Outperform Rating	24/02/23	MT
JMP Securities Adjusts Price Target on Generation Bio to $7 From $11, Maintains Market Outperform Rating	19/01/23	MT
Canaccord Genuity Starts Generation Bio at Buy With $9 Price Target	08/11/22	MT
JMP Securities Adjusts Generation Bio's Price Target to $11 from $10, Keeps Market Outperform Rating	08/08/22	MT
Needham Adjusts Generation Bio's Price Target to $23 from $27, Keeps Buy Rating	05/08/22	MT
Wedbush Adjusts Price Target for Generation Bio to $24 From $23, Maintains Outperform Rating	21/06/22	MT
Wedbush Lowers Generation Bio's Price Target to $23 From $25, Citing Cost of Capital, Keeps Outperform Rating	06/05/22	MT
Wedbush Cuts Generation Bio's Price Target to $25 From $31, Citing Pipeline Timeline Adjustments, Keeps Outperform Rating	25/02/22	MT
Jefferies Adjusts Price Target for Generation Bio to $29 From $38, Maintains Buy Rating	15/12/21	MT
JMP Securities Adjusts Price Target on Generation Bio to $10 From $40, Maintains Market Outperform Rating	15/12/21	MT
Needham Adjusts Price Target on Generation Bio to $27 From $50, Maintains Buy Rating	15/12/21	MT
JPMorgan Downgrades Generation Bio to Neutral From Overweight, Sets $17 Price Target	14/12/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Generation Bio Co.

Equities

GBIO

US37148K1007

Analyst Reco.

Filters